India to United States: Amikacin Export Trade Route
India has recorded 47 verified shipments of Amikacin exported to United States, representing a combined trade value of $3.2M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $67.7K USD. The leading Indian exporter is AVET LIFESCIENCES PRIVATE LIMITED, which accounts for 85% of total export value with 42 shipments worth $2.7M USD. On the buying side, AVET PHARMACEUTICALS INC. is the largest importer in United States with $1.6M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Amikacin corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $3.2M USD. The route is dominated by AVET LIFESCIENCES PRIVATE LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's amikacin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $67.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with amikacin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 27.2%, placing it at rank #6 among India's top amikacin export destinations globally.
On the import side, key buyers of Indian amikacin in United States include AVET PHARMACEUTICALS INC., AVET PHARMACEUTICALS INC. AVET PHARMACEUTICALS INC. is the single largest importer with 30 shipments valued at $1.6M USD.
